The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
I am not expecting a company with such massive growth over the past year to be in a position to post an accurate s set of figures within 20 working days of the year end. Their financial workload must have increased 10 fold.
But maybe an RNS giving us a date and saying that turnover is expected to be above market expectations would be good!
A lot of talk on the BBC news about the new strain being discovered by tests using Genomic Sequencing and this will be the testing method to concentrate on going forwards.
I know nothing about GS or if it is common to all available tests but is covered by NCYT.
"Your test goes onto a machine which amplifies the genomic sequence of the virus. That amplification is what allows you to identify the virus. You can imagine the virus sample is so small, so you amplify it with PCR technology that’s well known in the centralised labs. Novacyt’s test comes with all the reagents, essentially in vials."
From a BBC report on the new variant this morning, “MK LHL testing data showing increasing prevalence of H69/V70 variant in positive test data - which is detected incidentally by the commonly used 3-gene PCR test.”
Alamo, agree, i always thought giving it to the over 80's first was a risky strategy, sadly at that age there will be some who are in their final days of life unknowingly through natural causes and will die after the vaccine and the media will report it and put doubt in peoples minds.
I know its a difficult choice and it has to start somewhere but the last thing we need is to kill confidence in having it.
My post of 3/12, so typical!!!
"Now the media have run out of all of the good news on the vaccine they are predictably now looking for the negatives.
Wheeling out the experts to talk about all of the distribution and storage difficulties still to overcome.
Just wait until they start administering the vaccine they will all be circling like vultures waiting to report on the first adverse reaction!"
Link to the full document,
https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/941452/Information_for_healthcare_professionals.pdf
Now the media have run out of all of the good news on the vaccine they are predictably now looking for the negatives.
Wheeling out the experts to talk about all of the distribution and storage difficulties still to overcome.
Just wait until they start administering the vaccine they will all be circling like vultures waiting to report on the first adverse reaction!
Just watching a presenter on the BBC news talking about the different vaccines who said that none of the vaccines are being tested for those under 50 so therefore there will be a long wait before a vaccine is available for 50 and under. Has anyone else heard that before?
All the talk on here is mostly of testing but take a look at all of the different products available in the group divisions, https://novacyt.com/about-novacyt-group/ NCYT are not a one trick pony and now have the funds to make numerous of those products market leaders long after COVID is gone.